Literature DB >> 7769705

Isolation and characterization of a syncytium-inducing, macrophage/T-cell line-tropic human immunodeficiency virus type 1 isolate that readily infects chimpanzee cells in vitro and in vivo.

R Shibata1, M D Hoggan, C Broscius, G Englund, T S Theodore, A Buckler-White, L O Arthur, Z Israel, A Schultz, H C Lane.   

Abstract

Fresh human immunodeficiency virus type 1 (HIV-1) isolates from patients with AIDS were screened for infectivity in chimpanzee peripheral blood mononuclear cells (PBMC) to identify strains potentially able to generate high virus loads in an inoculated animal. Only 3 of 23 isolates obtained were infectious in chimpanzee cells. Of these three, only one (HIV-1DH12) was able to initiate a productive infection in PBMC samples from all 25 chimpanzees tested. HIV-1DH12 tissue culture infections were characterized by extremely rapid replication kinetics, profound cytopathicity, and tropism for chimp and human PBMC, primary human macrophage, and several human T-cell lines. An infection was established within 1 week of inoculating a chimpanzee with 50 50% tissue culture infective doses of HIV-1DH12; cell-free virus was recovered from the plasma at weeks 1, 2, and 4 and was associated with the development of lymphadenopathy. Virus loads during the primary infection and at 6 months postinoculation were comparable to those reported in HIV-1-seropositive individuals.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7769705      PMCID: PMC189187          DOI: 10.1128/JVI.69.7.4453-4462.1995

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  62 in total

1.  Long-term observation of baboons, rhesus monkeys, and chimpanzees inoculated with HIV and given periodic immunosuppressive treatment.

Authors:  W J Morrow; J Homsy; J W Eichberg; J Krowka; L Z Pan; I Gaston; H Legg; N Lerche; J Thomas; J A Levy
Journal:  AIDS Res Hum Retroviruses       Date:  1989-04       Impact factor: 2.205

2.  The NF-kappa B binding sites in the human immunodeficiency virus type 1 long terminal repeat are not required for virus infectivity.

Authors:  J Leonard; C Parrott; A J Buckler-White; W Turner; E K Ross; M A Martin; A B Rabson
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

Review 3.  Pathogenic diversity of simian immunodeficiency viruses.

Authors:  V M Hirsch; P R Johnson
Journal:  Virus Res       Date:  1994-05       Impact factor: 3.303

4.  Characterization of infectious molecular clones of simian immunodeficiency virus (SIVmac) and human immunodeficiency virus type 2: persistent infection of rhesus monkeys with molecularly cloned SIVmac.

Authors:  Y M Naidu; H W Kestler; Y Li; C V Butler; D P Silva; D K Schmidt; C D Troup; P K Sehgal; P Sonigo; M D Daniel
Journal:  J Virol       Date:  1988-12       Impact factor: 5.103

5.  HIV infection of chimpanzees as a model for testing chemotherapeutics.

Authors:  P N Fultz; H M McClure; R B Swenson; D C Anderson
Journal:  Intervirology       Date:  1989       Impact factor: 1.763

6.  The natural history of transfusion-associated infection with human immunodeficiency virus. Factors influencing the rate of progression to disease.

Authors:  J W Ward; T J Bush; H A Perkins; L E Lieb; J R Allen; D Goldfinger; S M Samson; S H Pepkowitz; L P Fernando; P V Holland
Journal:  N Engl J Med       Date:  1989-10-05       Impact factor: 91.245

7.  The biology of human immunodeficiency virus-1 IIIB infection in the chimpanzee: in vivo and in vitro correlations.

Authors:  P Nara; W Hatch; J Kessler; J Kelliher; S Carter
Journal:  J Med Primatol       Date:  1989       Impact factor: 0.667

8.  Identification and biologic characterization of an acutely lethal variant of simian immunodeficiency virus from sooty mangabeys (SIV/SMM).

Authors:  P N Fultz; H M McClure; D C Anderson; W M Switzer
Journal:  AIDS Res Hum Retroviruses       Date:  1989-08       Impact factor: 2.205

9.  Human immunodeficiency virus (HIV) from experimentally infected chimpanzees: isolation and characterization.

Authors:  B A Castro; C M Walker; M Tateno; C Cheng-Mayer; R Heberling; J W Eichberg; J A Levy
Journal:  J Med Primatol       Date:  1989       Impact factor: 0.667

10.  Biologic features of HIV-1 that correlate with virulence in the host.

Authors:  C Cheng-Mayer; D Seto; M Tateno; J A Levy
Journal:  Science       Date:  1988-04-01       Impact factor: 47.728

View more
  52 in total

1.  Preferential coreceptor utilization and cytopathicity by dual-tropic HIV-1 in human lymphoid tissue ex vivo.

Authors:  S Glushakova; Y Yi; J C Grivel; A Singh; D Schols; E De Clercq; R G Collman; L Margolis
Journal:  J Clin Invest       Date:  1999-09       Impact factor: 14.808

2.  Increased neutralization sensitivity and reduced replicative capacity of human immunodeficiency virus type 1 after short-term in vivo or in vitro passage through chimpanzees.

Authors:  T Beaumont; S Broersen; A van Nuenen; H G Huisman; A M de Roda Husman; J L Heeney; H Schuitemaker
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

3.  Augmentation of human immunodeficiency virus type 1 subtype E (CRF01_AE) multiple-drug resistance by insertion of a foreign 11-amino-acid fragment into the reverse transcriptase.

Authors:  H Sato; Y Tomita; K Ebisawa; A Hachiya; K Shibamura; T Shiino; R Yang; M Tatsumi; K Gushi; H Umeyama; S Oka; Y Takebe; Y Nagai
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

4.  Live, attenuated simian immunodeficiency virus vaccines elicit potent resistance against a challenge with a human immunodeficiency virus type 1 chimeric virus.

Authors:  R Shibata; C Siemon; S C Czajak; R C Desrosiers; M A Martin
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

5.  Use of coreceptors other than CCR5 by non-syncytium-inducing adult and pediatric isolates of human immunodeficiency virus type 1 is rare in vitro.

Authors:  Y J Zhang; T Dragic; Y Cao; L Kostrikis; D S Kwon; D R Littman; V N KewalRamani; J P Moore
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

6.  Administration of an anti-CD8 monoclonal antibody interferes with the clearance of chimeric simian/human immunodeficiency virus during primary infections of rhesus macaques.

Authors:  T Matano; R Shibata; C Siemon; M Connors; H C Lane; M A Martin
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

7.  Rapid CD4(+) T-cell loss induced by human immunodeficiency virus type 1(NC) in uninfected and previously infected chimpanzees.

Authors:  F J Novembre; J de Rosayro; S Nidtha; S P O'Neil; T R Gibson; T Evans-Strickfaden; C E Hart; H M McClure
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

8.  Human immunodeficiency virus type 1 Vpr protein does not modulate surface expression of the CD4 receptor.

Authors:  Enrique Argañaraz; María José Cortés; Sydney Leibel; Juan Lama
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

9.  Neutralizing antibody titers conferring protection to macaques from a simian/human immunodeficiency virus challenge using the TZM-bl assay.

Authors:  Ronald Willey; Martha C Nason; Yoshiaki Nishimura; Dean A Follmann; Malcolm A Martin
Journal:  AIDS Res Hum Retroviruses       Date:  2010-01       Impact factor: 2.205

10.  Induction of disease by a molecularly cloned highly pathogenic simian immunodeficiency virus/human immunodeficiency virus chimera is multigenic.

Authors:  Reza Sadjadpour; Theodore S Theodore; Tatsuhiko Igarashi; Olivia K Donau; Ronald J Plishka; Alicia Buckler-White; Malcolm A Martin
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.